Sexually transmitted infections (STIs) are far more common than many people realize—and most don’t come with obvious symptoms. In fact, you can carry and pass on an STI without ever knowing it. This silent nature is what makes regular testing so important. For instance, chlamydia and gonorrhea often show no signs at all, especially in their early stages, yet they can still cause long-term health issues if left untreated. Studies have shown that a significant portion of people—whether pregnant women, HIV-positive men who have sex with men, or others—live with asymptomatic STIs without any clue they’re infected.
Despite outdated assumptions, STI testing isn’t just for “other people” or emergencies. It’s a proactive way to take care of your health, your relationships, and your future. Regular screening helps detect infections before they cause complications like infertility or chronic pelvic pain. It also supports healthier relationships by fostering honest conversations and reducing the risk of unknowingly passing an infection to someone you care about. Even in monogamous or long-term partnerships, testing still matters—especially if either partner hasn’t been tested before or may have had an untreated infection in the past.
This article will walk you through why regular STI testing is essential, when you should get tested, and how to make it a natural part of your health routine. Whether you’re navigating new relationships, managing your sexual health, or just making self-care a priority, testing is a simple and powerful tool to help you do it confidently.
Why Regular Testing Matters
One of the biggest challenges with sexually transmitted infections is how quietly they can spread. Most STIs, including chlamydia, gonorrhea, and even syphilis, often don’t cause any noticeable symptoms—especially in their early stages. Without routine testing, these infections can go undetected for months or even years, continuing to spread from person to person while silently harming the body. Among young adults in particular, high rates of asymptomatic infections have been documented, which helps explain why some STIs remain so persistent in communities despite screening efforts.
Because of this, it’s entirely possible to pass an STI to someone else without realizing you have one. Even people who feel fine or assume they’re low-risk can unknowingly carry and transmit infections like HPV, herpes, or syphilis. And when symptoms do appear, many delay seeking care—sometimes because of stigma, sometimes out of fear or uncertainty. But during this delay, sexual activity continues, and so does the risk of transmission.
Beyond spreading silently, untreated STIs can have serious and lasting health consequences. Infections like chlamydia and gonorrhea can lead to pelvic inflammatory disease, infertility, and complications during pregnancy. Others, like HPV, are linked to certain types of cancer, including cervical cancer. Even when infections don’t appear life-threatening, they can still affect long-term health and quality of life through chronic pain or inflammation.
This is where regular testing becomes powerful. It interrupts that chain of silent transmission by catching infections early—often before symptoms ever appear. But just as importantly, routine screening helps shift how we think about sexual health. When testing is seen as a normal part of healthcare, rather than a reaction to something going wrong, it helps reduce shame and encourages open conversations. In the long run, this not only improves individual outcomes, but also supports healthier communities where care and prevention are shared values.
When Should You Get Tested?
Knowing when to get tested for STIs is just as important as the act itself. While everyone’s situation is different, there are some key moments when screening is strongly recommended—for both your own health and the well-being of your partners.
Before Starting a New Relationship
If you’re about to become sexually active with someone new, getting tested is one of the most respectful and responsible things you can do. It helps establish a baseline for your sexual health and gives both of you peace of mind. Even if you feel healthy, asymptomatic infections are common, and proactive testing can prevent them from being unknowingly passed on. For younger adults and teens in particular, this simple step has been shown to lower STI rates in new relationships.
Every 3 to 12 Months if You Have Multiple Partners
For those with more than one sexual partner—especially within high-risk groups like men who have sex with men—routine screening is essential. Depending on your level of activity and risk, testing every 3 to 12 months can significantly reduce the spread of infections that often fly under the radar, like chlamydia and gonorrhea. Sticking to a regular schedule helps catch infections early and supports community-wide health.
After Unprotected Sex
If you’ve had unprotected sex with a new or unknown-status partner, it’s important to get tested as soon as possible. While some infections may not show up immediately, early screening can catch many STIs in time for treatment that prevents complications and further transmission. This is particularly important because positivity rates tend to be higher among people who report recent unprotected encounters.
When You Notice Symptoms
Any new or unusual symptoms—like burning during urination, genital sores, itching, pain, or discharge—should prompt immediate testing. Even if the symptoms are mild, they could signal something more serious, such as gonorrhea, syphilis, or herpes. Getting checked quickly can prevent infections from progressing and help protect your future health.
As Part of Routine Health Care
STI testing isn’t just for emergencies—it should be part of regular medical care, especially if you’re under 25 or pregnant. Young adults face higher rates of certain infections, and annual screening is strongly recommended. For those who are pregnant, STI testing is part of standard prenatal care because untreated infections can affect both maternal and infant health.
Building testing into your regular routine—not just when something feels off—makes it easier, less stressful, and more effective at keeping you and your partners healthy.
What STIs Should You Be Tested For?
Not every STI test is automatically included in a standard screening panel. What you’re tested for often depends on your age, sexual activity, medical history, and any specific risks you might have. Understanding what’s typically included—and what requires a separate request—can help you make informed decisions about your sexual health.
The Core Tests: What’s Usually Included
For most sexually active individuals, especially those under 25, routine STI screening typically covers:
- Chlamydia
As the most commonly reported bacterial STI, chlamydia often shows no symptoms but can lead to serious complications if untreated. Regular screening is especially important for younger people and those with new or multiple partners. - Gonorrhea
Gonorrhea frequently coexists with chlamydia and is another bacterial infection that’s often silent. It’s particularly prevalent in young adults and among individuals living with HIV, making regular testing crucial for early detection and treatment. - HIV
Routine HIV testing is vital for everyone, regardless of perceived risk. Catching HIV early allows for timely treatment, which not only improves long-term health outcomes but also significantly lowers the risk of transmission. - Syphilis
Once considered a historical disease, syphilis is now on the rise in many communities. Public health guidelines recommend routine testing for at-risk groups, including men who have sex with men and people who are pregnant.
Tests to Consider Based on Risk or Personal Choice
Some infections aren’t always included in standard panels but may be recommended based on your situation:
- Herpes (HSV-1 and HSV-2)
Herpes is extremely common, yet testing isn’t routinely done unless you have symptoms or a known exposure. If you’re curious about your status or have had a partner with herpes, you can request a type-specific blood test. Just be aware that a diagnosis can come with emotional impacts, so it’s worth discussing with a healthcare provider first. - HPV (Human Papillomavirus)
For people with a cervix, routine Pap smears help detect changes caused by HPV and prevent cervical cancer. While HPV is widespread and often clears on its own, screening is essential for catching high-risk types early. - Hepatitis B and C
These liver infections are more common in people with a history of injection drug use, multiple sexual partners, or past STIs. Testing is important not only for personal health, but also to reduce the risk of unknowingly passing the virus to others.
A Note About Herpes Testing
Because of its lifelong nature and the lack of a cure, herpes testing is not usually part of a routine STI panel unless you ask for it. The CDC doesn’t recommend screening asymptomatic people without a known exposure, largely to avoid unnecessary distress. Still, if knowing your full STI status matters to you or your partner, you have the right to request herpes testing—just be sure to discuss it with a knowledgeable provider.
Ultimately, the goal of STI testing isn’t just to check boxes—it’s to stay informed and empowered in your sexual health decisions. Knowing which infections to screen for and when to ask for additional tests gives you control and clarity in your care.
Where Can You Get Tested?
Accessing STI testing is easier and more flexible than ever. Whether you prefer a clinical setting, need low-cost options, or want to test from the privacy of home, there’s a solution that fits your needs. The most important thing is that testing remains confidential, affordable, and free of judgment—no matter where you go.
Community Sexual Health Clinics
Local clinics are a cornerstone of STI testing services, especially for people who may not have private insurance or access to a regular doctor. These clinics often offer low-cost or free testing, rapid results, and immediate connections to care if needed. They’re particularly valuable for high-risk populations, including LGBTQ+ communities and young adults. Unlike some hospital environments, community clinics are typically designed with privacy and approachability in mind, which can make testing feel less intimidating.
Primary Care and OB-GYN Visits
If you already see a primary care doctor or gynecologist, STI testing can often be incorporated into your regular visits. This makes it easy to include sexual health in your overall wellness routine. While some patients—especially younger LGBTQ+ individuals—may feel uneasy bringing up sexual health topics in these settings, many providers are trained to offer comprehensive and respectful care. If you don’t feel comfortable, it’s okay to ask for someone who is more experienced with inclusive sexual health support.
LGBTQ+ Health Centers
For those seeking care that’s specifically attuned to the needs of LGBTQ+ individuals, dedicated health centers can offer a more affirming experience. These facilities are often staffed by providers who understand the unique barriers LGBTQ+ patients face in traditional healthcare, including stigma and lack of cultural competence. Many of these centers also engage in targeted outreach, helping to improve STI testing rates in underserved groups like transgender, gay, and bisexual individuals.
At-Home Test Kits
At-home STI test kits are an increasingly popular option for people who value privacy and convenience. Available through trusted providers, these kits allow you to collect your own samples—such as a urine, swab, or blood sample—and mail them in for lab testing. They’re especially helpful for people in rural areas, those with mobility challenges, or anyone who simply prefers not to visit a clinic. Studies show that users overwhelmingly report high satisfaction with the process, and these services are expanding access to early diagnosis and treatment.
The Bottom Line
No matter where or how you get tested, the experience should feel safe, respectful, and accessible. Confidentiality is key. So is affordability—many testing services are free or subsidized, especially for students, uninsured individuals, or those at higher risk. Most of all, STI testing should never feel like something to be ashamed of. It’s a normal, responsible part of health care—and choosing a setting that supports that mindset makes all the difference.
What Happens During an STI Test?
If you’ve never had an STI test before—or if it’s been a while—it’s completely natural to feel a bit nervous. But the process is likely quicker, easier, and more comfortable than you might expect. Today’s STI testing is designed to be efficient, respectful, and adaptable to your needs.
What the Test Involves
STI testing isn’t one-size-fits-all. Depending on your sexual history, symptoms, and risk factors, you might be asked to provide a blood sample, urine sample, or a swab from a specific area of the body.
- Blood tests are commonly used to check for infections like HIV, syphilis, and sometimes herpes.
- Urine samples are typically used to detect chlamydia and gonorrhea.
- Swabs may be taken from the throat, vagina, rectum, or penis—depending on your sexual practices—to identify site-specific infections.
Some clinics even offer self-collection options, such as self-swabbing, which can be more comfortable for many people and just as accurate as clinician-collected samples.
Fast and Streamlined
Most tests are quick and can be completed in under 30 minutes. Whether you’re in a clinic or using a trusted at-home kit, modern diagnostic tools like multiplex PCR tests allow providers to check for multiple infections from a single sample. That means less time waiting and fewer return visits.
No Judgment, Just Care
Even though STI testing can feel personal, today’s process is designed with your privacy and comfort in mind. Many people report that the experience is far less intimidating than they expected, especially with the availability of non-invasive methods and greater provider sensitivity to patient concerns. Whether you choose an in-person visit or a self-collection kit, the emphasis is on making the experience as smooth and stress-free as possible.
Getting tested is simply one more way to take care of yourself. And the more you do it, the easier—and more routine—it becomes.
What If You Test Positive?
A positive STI result can stir up a lot of emotions—shock, worry, fear—but the most important thing to know is this: you’re not alone, and you’re not in danger. Many STIs are easily treated, and all are manageable with the right care. Testing positive simply means you took an informed step toward protecting your health and the health of others.
Most STIs Are Treatable—Many Are Curable
Bacterial STIs like chlamydia, gonorrhea, and syphilis can typically be cured with antibiotics, often in just a single dose or short course of medication. Even viral infections like herpes or HIV, which stay in the body long term, can be effectively managed with ongoing treatment. Early diagnosis gives you access to care that can prevent complications and support long-term health—and today’s treatment options are far more advanced and accessible than ever before.
Care Is Often Quick, Affordable, and Discreet
For most people, treatment is straightforward. Many public clinics offer free or low-cost medications, and some pharmacies or telehealth services provide discreet delivery if privacy is a concern. The earlier you get treatment, the better your outcomes—and in many cases, there are no lasting effects once the infection is resolved.
You Can—and Should—Inform Partners
Letting past or current partners know is a key step in stopping the spread of STIs. It also gives them the chance to get tested and treated if needed. This doesn’t mean you have to do it alone—clinics often offer confidential partner notification services, where healthcare providers can reach out anonymously on your behalf. Many people are open to telling their partners but feel nervous about how it will go. Having support, whether from a provider or a trusted friend, can make that conversation easier.
Your Diagnosis Does Not Define You
Testing positive isn’t a reflection of who you are—it’s a sign that you took charge of your health. STIs are common, and they’re not a moral failing. Reducing the stigma around sexual health is part of making care more accessible and compassionate. In fact, many people report that a positive test led them to adopt healthier sexual practices moving forward, from more open communication with partners to consistent condom use.
Remember, sexual health is part of overall health—and taking steps to protect it is something to be proud of.
Testing as Empowerment, Not Shame
Too often, STI testing is treated like a punishment or something you only do when you think something is wrong. But the truth is, getting tested is one of the most empowering actions you can take for your health. It’s not about fear—it’s about care. And shifting that mindset changes everything.
Reframing Testing as a Wellness Practice
When STI screening is framed as a routine part of self-care—just like brushing your teeth or going to a yearly physical—it loses its stigma. It becomes something you do because you value your body, your health, and your future. For young adults especially, viewing testing as a proactive health habit helps reduce the internalized shame that’s often associated with sexual health. Public health campaigns that normalize STI testing as part of everyday wellness are already helping to reframe it as something responsible, not reactionary.
A Sign of Respect—for Yourself and Others
Choosing to get tested regularly isn’t just about personal peace of mind—it’s a clear expression of care for your partners, too. It sets the tone for trust, open communication, and mutual responsibility in relationships. It says: “I respect both of us enough to make this a priority.” When seen through that lens, testing isn’t just a medical task—it’s an act of connection, honesty, and accountability.
Normalizing Testing Reduces Shame for Everyone
The more we talk openly about STI testing—and the more accessible we make it through clinics, at-home kits, and peer-led initiatives—the less room there is for shame. Making testing visible and ordinary helps people feel less alone and more in control of their health. For those in marginalized communities who often face extra layers of stigma, supportive and inclusive approaches to testing can also help reduce anxiety and improve overall mental well-being.
Empowerment through knowledge, care through action—that’s what STI testing is really about. When we treat it as a normal, healthy choice, we open the door to safer, more confident, and more compassionate lives.
Caring for Your Health Starts with Awareness
Taking care of your sexual health is a powerful act of self-respect. As we’ve seen throughout this article, STI testing isn’t just something you do in response to a scare—it’s a normal, important part of staying well. It protects your body, strengthens your relationships, and helps create a culture where open, shame-free conversations about health are the norm.
Whether you’re navigating a new relationship, checking in after an unprotected encounter, or simply keeping testing part of your regular routine, each step you take is a sign of care—for yourself and those around you. With testing more accessible, private, and supportive than ever, there’s every reason to treat it as an essential part of your overall wellness.
If you found this article helpful, we’d love to stay connected. Join our mailing list for more resources, new articles, and practical tools to support your sexual health journey. We’re here to make it easier, clearer, and a lot less overwhelming—every step of the way.
References
Ahn, J., Kim, D., Lee, W., Yoon, S., & Cho, S. (2023). B-226 Clinical Evaluation of ElsiQ™ STI-12 Detection Kit 3/4 for Detection of Human Sexual Transmitted Infection Pathogens in Human Vaginal Swab and/or Urine Specimens. Clinical Chemistry.
Alarcón Gutiérrez, M., Palma Díaz, D., Forns Cantón, M. L., Fernández-López, L., García de Olalla, P., & Rius Gibert, C. (2024). Trends in Sexual Health of Gay, Bisexual, and Other Men Who Have Sex with Men, and Transgender Individuals: Apps Driven Testing Program for HIV and Other STIs in Barcelona, Spain (2016-2023). Journal of community health, 49(3), 429–438.
Anderson, T.A., Hensel, D.J., He, F., Harezlak, J., & Fortenberry, J.D. (2013). P3.081 Time to Sexually Transmitted Infections After Negative STI Testing Among Young Adults. Sexually Transmitted Infections, 89, A173 – A173.
Begum, H., Gadient, S., Bullard, J., Gratrix, J., Grennan, T., Hatchette, T., & Fleurant-Ceelen, A. (2024). Summary of the National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI) Statement: Recommendations on Screening for Syphilis in Non-Pregnant Adults and Adolescents. Canada Communicable Disease Report, 50, 233–240.
Cassell, J. (2018). Public health aspects of STIs including partner notification. Medicine, 46, 265-268.
Chandra, C., Weiss, K. M., Kelley, C. F., Marcus, J. L., & Jenness, S. M. (2021). Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(7), e2261–e2269.
Christensen, B. L., Shukalek, C., Kwon, G., Hill, N. E., Church, D. L., Naugler, C., Kim, J., & Somayaji, R. (2023). Comprehensive at-home Sexually Transmitted and Blood Borne Infection (STBBI) Testing Program: A Pilot Initiative. Open Forum Infectious Diseases, 10.
Creswell, J., Guardado, M. E., Lee, J., Nieto, A. I., Kim, A. A., Monterroso, E., & Paz-Bailey, G. (2012). HIV and STI control in El Salvador: results from an integrated behavioural survey among men who have sex with men. Sexually transmitted infections, 88(8), 633–638.
Cullinen, K., Hill, M., Anderson, T., Jones, V., Nelson, J., Halawani, M., & Zha, P. (2021). Improving sexually transmitted infection screening, testing, and treatment among people with HIV: A mixed method needs assessment. PLoS ONE, 16.
Denison, H. (2017). Healthcare-seeking behaviour for sexually transmitted infection testing in New Zealand: A mixed methods study.
Dude, A. M., Drexler, K., Yee, L. M., & Badreldin, N. (2023). Adherence to Sexually Transmitted Infection Screening in Pregnancy. Journal of women’s health (2002), 32(6), 652–656.
Duffus W. A. (2015). Commentary on “Effectiveness of an urban emergency department call-back system in the successful linkage to treatment of sexually transmitted infections”. Southern medical journal, 108(5), 274–275.
Duracinsky, M., Dimi, S., Carrieri, M., Yaya, I., Villes, V., Valin, N., Farfour, E., Chassany, O., & Zucman, D. (2022). Risk Prediction Score for Screening Asymptomatic Sexually Transmitted Infections in HIV-positive French Men Who Have Sex with Men (ANRS 9520 DRIVER). American Journal of Health Behavior, 46(5), 558–566.
Govender, V., Moodley, D., Naidoo, M., Connoly, C., Ngcapu, S., & Abdool Karim, Q. (2024). Sexually transmitted infections in pregnancy and adverse pregnancy outcomes: A retrospective cohort study. International Journal of Gynecology & Obstetrics, 166, 62–70.
Goyal, M. K., Teach, S. J., Badolato, G. M., Trent, M., & Chamberlain, J. M. (2016). Universal Screening for Sexually Transmitted Infections among Asymptomatic Adolescents in an Urban Emergency Department: High Acceptance but Low Prevalence of Infection. The Journal of pediatrics, 171, 128–132.
Green, H., Taleghani, S., Nyemba, D., Myer, L., & Davey, D. J. (2020). Partner notification and treatment for sexually transmitted infections among pregnant women in Cape Town, South Africa. International journal of STD & AIDS, 31(13), 1282–1290.
Kang, M. (2015). Sex, young people and chlamydia: reducing the impact. Sexual Health.
Keaveney, S., Sadlier, C., O’Dea, S., Delamere, S., & Bergin, C. (2014). High prevalence of asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: a stimulus to improve screening. International journal of STD & AIDS, 25(10), 758–761.
Larney, S., Hado, S., McKenzie, M., & Rich, J. D. (2014). Unknown quantities: HIV, viral hepatitis, and sexually transmitted infections in community corrections. Sexually transmitted diseases, 41(4), 283.
Lawson, R. M. (2021). HIV and Other Sexually Transmitted Infections: Screening Recommendations. The Journal for Nurse Practitioners.
Liddon, N., Pampati, S., Dunville, R., Kilmer, G., & Steiner, R. J. (2022). Annual STI Testing Among Sexually Active Adolescents. Pediatrics, 149(5), e2021051893.
Loerinc, L., Scheel, A., Jordan-Thompson, S., Gillespie, S., & Camacho-Gonzalez, A. (2022). Incidence, Reinfection, and Discrepancy Between Sexual Practice and Anatomic Site Positivity of Sexually Transmitted Infections in Youth With HIV. The Pediatric infectious disease journal, 41(4), 306–311.
Martínez-Riveros, H., Soler, V. G., Díaz, Y., Montoro-Fernández, M., Fernandez-Rivas, G., Pericas, C., Palma, D., Villar, M., Adell, H., Gonzalez Quiles, H., Sotomayor Cortés, J., Gomez, S., Ramirez Marinero, A., Romano-de Gea, P., Muntada, E., Casabona, J., & Agusti, C. (2025). TESTATE STI project: an online chlamydia and gonorrhoea self-sampling strategy. Sexually Transmitted Infections.
Mcdonagh, L., Omran, L., Curtis, T. J., Pach, S., Saunders, J., Cassell, J., & Rait, G. (2019). ‘You feel invisible’: a qualitative exploration of young LGBT+ people’s attitudes towards STI/HIV testing in primary care. Sexually Transmitted Infections, 95, A63.
Melendez, J. H., Muñiz Tirado, A., Onzia, A., Mande, E., Hardick, J., Parkes-Ratanshi, R., Hamill, M. M., & Manabe, Y. C. (2024). Self-collected penile-meatal swabs are suitable for the detection of STIs in Ugandan men with high rates of STI coinfections. Sexually Transmitted Infections.
Mimiaga, M. J., Thomas, B., Mayer, K. H., Regenauer, K. S., Dange, A., Andres Bedoya, C., Rawat, S., Balu, V., O’Cleirigh, C., Biello, K. B., Anand, V., Swaminathan, S., & Safren, S. A. (2018). A randomized clinical efficacy trial of a psychosocial intervention to strengthen self-acceptance and reduce HIV risk for MSM in India: study protocol. BMC public health, 18(1), 890.
Morris, J. L., Lippman, S. A., Philip, S., Bernstein, K., Neilands, T. B., & Lightfoot, M. (2014). Sexually transmitted infection related stigma and shame among African American male youth: implications for testing practices, partner notification, and treatment. AIDS patient care and STDs, 28(9), 499–506.
Ndiaye, B., Seck, A., Diop, A., Dieng, A., Diallo, T., Mahou, C., & Dubrous, P. (2022). Prevalence of Sexually Transmitted Chlamydia trachomatis and Neisseria gonorrhoeae Infections in an Asymptomatic Population in Dakar, Senegal. Microbiology Research Journal International.
Oeser, C., Sonnenberg, P., Unemo, M., Sadler, K., Clifton, S., Gibbs, J., Beddows, S., Hamilton, R., Roodt, A., Migchelsen, S., Dema, E., David, A., Mercer, C. H., & Field, N. (2025). Home-based self-collection of biological samples, including vaginal swabs: a mixed methods study for Britain’s fourth National Survey of Sexual Attitudes and Lifestyles (Natsal-4). Sexually Transmitted Infections.
Ooi, C., & Dayan, L. (2004). STIs in pregnancy. An update for GPs. Australian Family Physician, 33(9), 723–726.
Ott, M. A., Harezlak, J., Ofner, S., & Fortenberry, J. D. (2012). Timing of incident STI relative to sex partner change in young women. Sexually transmitted diseases, 39(10), 747–749.
Patel, C. G., & Tao, G. (2022). STI/HIV Testing and Prevalence of Gonorrhea and Chlamydia Among Persons with Their Specified-Type Sex Partner. The American journal of medicine, 135(2), 196–201.
Reed, J. L., Huppert, J. S., Gillespie, G. L., Taylor, R. G., Holland, C. K., Alessandrini, E. A., & Kahn, J. A. (2015). Adolescent patient preferences surrounding partner notification and treatment for sexually transmitted infections. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 22(1), 61–66.
Rieg, G., Lewis, R. J., Miller, L. G., Witt, M. D., Guerrero, M., & Daar, E. S. (2008). Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS patient care and STDs, 22(12), 947–954.
Sri-Pathmanathan, C., Nhamo, D., Mamvuto, T., Chapwanya, G., Terris-Prestholt, F., Mahaka, I., Marks, M., & Tucker, J. D. (2022). Syphilis self-testing to expand test uptake among men who have sex with men: a theoretically informed mixed methods study in Zimbabwe. Sexually transmitted infections, 98(3), 197–202.
Tan, R., Kaur, N., Kumar, P. A., Tay, E., Leong, A., Chen, M., & Wong, C. S. (2020). Clinics as spaces of costly disclosure: HIV/STI testing and anticipated stigma among gay, bisexual and queer men. Culture, Health & Sexuality, 22, 307–320.
Tang, E. C., Vittinghoff, E., Philip, S. S., Doblecki-Lewis, S., Bacon, O., Chege, W., Coleman, M. E., Elion, R., Buchbinder, S., Kolber, M. A., Liu, A. Y., & Cohen, S. E. (2020). Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis. AIDS (London, England), 34(8), 1181–1186.
Tao, G., & Patel, C. (2021). Sexually Transmitted Infection/HIV Testing Among Medicaid/Children’s Health Insurance Program-Insured Enrollees Aged 15 to 60 Years Who Were Diagnosed With High-Risk Sexual Behaviors With Their Opposite-Sex or Same-Sex Partners. Sexually transmitted diseases, 48(7), 488–492.
Tao, G., Patel, C. G., He, L., & Workowski, K. (2024). STI/HIV testing, STIs, and HIV PrEP use among men who have sex with men (MSM) and men who have sex with men and women (MSMW) in United States, 2019-2022. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciae314. Advance online publication.
Thomas, J. A., Ditchman, N., & Beedle, R. B. (2022). The impact of knowledge, self-efficacy, and stigma on STI testing intention among college students. Journal of American college health : J of ACH, 70(5), 1415–1425.
Van Gerwen, O. V., Austin, E., Bethune, C. W., Sullivan, P., & Muzny, C. (2023). Sexual healthcare and at-home STI test collection: attitudes and preferences of transgender women. Frontiers in Public Health, 11.
van Wees, D. A., Heijne, J. C. M., Heijman, T., Kampman, K. C. J. G., Westra, K., de Vries, A., Kretzschmar, M. E. E., & den Daas, C. (2018). Study protocol of the iMPaCT project: a longitudinal cohort study assessing psychological determinants, sexual behaviour and chlamydia (re)infections in heterosexual STI clinic visitors. BMC infectious diseases, 18(1), 559.
Wayal, S., Cassell, J., Edwards, S., & Hart, G. (2012). Sexual partnership patterns and sexually transmitted infections in HIV positive men who have sex with men: implications for partner notification. Sexually Transmitted Infections, 88, A7–A8.
Willekens, R., Sánchez, I., Miguel, L., Esperalba, J., Serra-Pladevall, J., Martin, M., Navarro, J., Falcó, V., Burgos, J., Ribera, E., & Curran, A. (2020). Screening for asymptomatic STIs in HIV-infected men who have sex with men. Sexually Transmitted Infections, 97, 170–171.
Williams, C. (2023). Addressing the Sexually Transmitted Infections Epidemic in the United States: A Sociomedical Perspective. Frontiers Research Topics.
Workowski, K., & Berman, S. (2021). Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. Clinical Infectious Diseases.
